NCT01146080View on ClinicalTrials.gov

Optical Coherence Tomography for EVERolimus Eluting STent

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Coronary Artery Disease
Interventions
DEVICE

Promus Element

Promus Element implanted to treat coronary artery lesions.

DEVICE

Promus

Promus stent implanted to treat coronary artery lesions

Trial Locations (1)

24128

Cardiovascular Department Ospedali Riuniti di Bergamo, Bergamo

Sponsors
All Listed Sponsors
collaborator

Case Western Reserve University

OTHER

collaborator

Boston Scientific Corporation

INDUSTRY

lead

A.O. Ospedale Papa Giovanni XXIII

OTHER